Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thanai Pongdee
James T Li

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Allergy and Clinical Immunology|November 14, 2024
Omalizumab safety concernsThanai Pongdee, James T Li
Mayo Clinic Proceedings|January 7, 2018
Evaluation and Management of Penicillin AllergyThanai Pongdee, James T Li
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 30, 2013
Exercise-induced bronchoconstrictionThanai Pongdee, James T Li
The World Allergy Organization Journal|August 19, 2022
Current and emerging biologic therapies targeting eosinophilic disordersMitchell M Pitlick, James T Li, Thanai Pongdee
The World Allergy Organization Journal|January 25, 2023
Risks and safety of biologics: A practical guide for allergistsAndrea N Sitek, James T Li, Thanai Pongdee
Current Allergy and Asthma Reports|January 18, 2024
Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation SyndromeDayne Voelker, Thanai Pongdee
The World Allergy Organization Journal|October 21, 2022
Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory DiseasesMitchell M Pitlick, Thanai Pongdee
Current Opinion in Allergy and Clinical Immunology|January 2, 2025
Biomarkers in the diagnosis of mast cell activationDayne Voelker, Thanai Pongdee
Therapeutic Advances in Respiratory Disease|March 18, 2025
Adverse effects of biologics used to treat asthmaAndrea Sitek, Sergio E Chiarella, Thanai Pongdee
Immunology and Allergy Clinics of North America|July 16, 2018
Mast Cell Mediators of Significance in Clinical Practice in MastocytosisJoseph H Butterfield, Anupama Ravi, Thanai Pongdee
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Allergy and Clinical Immunology|November 14, 2024
Omalizumab safety concernsThanai Pongdee, James T Li
Mayo Clinic Proceedings|January 7, 2018
Evaluation and Management of Penicillin AllergyThanai Pongdee, James T Li
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 30, 2013
Exercise-induced bronchoconstrictionThanai Pongdee, James T Li
The World Allergy Organization Journal|August 19, 2022
Current and emerging biologic therapies targeting eosinophilic disordersMitchell M Pitlick, James T Li, Thanai Pongdee
The World Allergy Organization Journal|January 25, 2023
Risks and safety of biologics: A practical guide for allergistsAndrea N Sitek, James T Li, Thanai Pongdee
Current Allergy and Asthma Reports|January 18, 2024
Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation SyndromeDayne Voelker, Thanai Pongdee
The World Allergy Organization Journal|October 21, 2022
Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory DiseasesMitchell M Pitlick, Thanai Pongdee
Current Opinion in Allergy and Clinical Immunology|January 2, 2025
Biomarkers in the diagnosis of mast cell activationDayne Voelker, Thanai Pongdee
Therapeutic Advances in Respiratory Disease|March 18, 2025
Adverse effects of biologics used to treat asthmaAndrea Sitek, Sergio E Chiarella, Thanai Pongdee
Immunology and Allergy Clinics of North America|July 16, 2018
Mast Cell Mediators of Significance in Clinical Practice in MastocytosisJoseph H Butterfield, Anupama Ravi, Thanai Pongdee
Pageof 8